Non-antiarrhythmic drugs prolonging the QT interval:considerable use in seven countries-Reference-Cited by-同舟云学术

Non-antiarrhythmic drugs prolonging the QT interval:considerable use in seven countries

Published:2002-08 Issue:2 Volume:54 Page:171-177
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:

Author:

De Ponti Fabrizio,Poluzzi Elisabetta,Vaccheri Alberto,Bergman Ulf,Bjerrum Lars,Ferguson John,Frenz Kerry J.,McManus Peter,Schubert Ingrid,Selke Gisbert,Terzis-Vaslamatzis Georgia,Montanaro Nicola

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2125.2002.01617.x/fullpdf

Reference23 articles.

1. QT interval. A measure of drug action;Woosley;Am J Cardiol,1993

2. Risk of ventricular arrhythmias associated with nonsedating antihistamine drugs;De Abajo;Br J Clin Pharmacol,1999

3. QT-interval prolongation by non-cardiac drugs: lessons to be learned from recent experience;De Ponti;Eur J Clin Pharmacol,2000

4. Drug-induced torsade de pointes: from molecular biology to bedside;Tamargo;Jpn J Pharmacol,2000

5. Drug-induced proarrhythmic effects. Assessment of changes in QT interval;Sheridan;Br J Clin Pharmacol,2000

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Data-driven drug-induced QT prolongation surveillance using adverse reaction signals derived from 12-lead and continuous electrocardiogram data;PLOS ONE;2022-01-31

2. Drug Interaction between Dexamethasone and Ketoprofen with Thiopental in Male Dogs: Effect on the Recovery from Anesthesia and Pharmacokinetics Parameters;Veterinary Medicine International;2022-01-18

3. Drug Interactions for Patients with Respiratory Diseases Receiving COVID-19 Emerged Treatments;International Journal of Environmental Research and Public Health;2021-11-08

4. Clinical Trials in a Dish: A Perspective on the Coming Revolution in Drug Development;SLAS DISCOVERY: Advancing the Science of Drug Discovery;2018-06-04

5. Comparative Safety of Sulfonylureas and the Risk of Sudden Cardiac Arrest and Ventricular Arrhythmia;Diabetes Care;2018-02-02